nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of clinical studies evaluating combinations of immune checkpoint inhibitors with locoregional treatments in solid tumors
|
Bertaglia, Valentina |
|
|
67 |
C |
p. 1-10 |
artikel |
2 |
Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment
|
Xiang, Xuan |
|
|
67 |
C |
p. 35-48 |
artikel |
3 |
Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy
|
Li, Wei |
|
|
67 |
C |
p. 49-57 |
artikel |
4 |
Corrigendum to “Dually modified transmembrane proteoglycans in development and disease” [Cytokine Growth Factor Rev. 39 (2018) 124–136]
|
Jenkins, Laura M. |
|
|
67 |
C |
p. 105 |
artikel |
5 |
Editorial Board
|
|
|
|
67 |
C |
p. ii |
artikel |
6 |
Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity
|
Zhou, Pengcheng |
|
|
67 |
C |
p. 80-88 |
artikel |
7 |
Retard or exacerbate: Role of long non-coding RNA growth arrest-specific 5 in the fibrosis
|
Xiang, Zhang |
|
|
67 |
C |
p. 89-104 |
artikel |
8 |
Revisiting PD-1/PD-L pathway in T and B cell response: Beyond immunosuppression
|
Lu, Jian |
|
|
67 |
C |
p. 58-65 |
artikel |
9 |
Role of the Wnt and GTPase pathways in breast cancer tumorigenesis and treatment
|
Ebrahimi, Nasim |
|
|
67 |
C |
p. 11-24 |
artikel |
10 |
The IL-2A receptor pathway and its role in lymphocyte differentiation and function
|
Li, Yuqian |
|
|
67 |
C |
p. 66-79 |
artikel |
11 |
The NOTCH4-GATA4-IRG1 axis as a novel target in early-onset colorectal cancer
|
Scheurlen, Katharina M. |
|
|
67 |
C |
p. 25-34 |
artikel |